Concepts (156)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiomyopathy, Hypertrophic | 7 | 2020 | 1339 | 1.340 |
Why?
|
| Magnetic Resonance Imaging, Cine | 8 | 2024 | 1094 | 1.270 |
Why?
|
| Gadolinium | 4 | 2020 | 965 | 0.730 |
Why?
|
| Ventricular Function, Left | 6 | 2024 | 3928 | 0.700 |
Why?
|
| Plaque, Atherosclerotic | 2 | 2022 | 1529 | 0.700 |
Why?
|
| Ventricular Remodeling | 5 | 2020 | 1272 | 0.620 |
Why?
|
| Myocardium | 11 | 2021 | 4760 | 0.570 |
Why?
|
| Image Interpretation, Computer-Assisted | 8 | 2020 | 3356 | 0.560 |
Why?
|
| Echocardiography, Doppler | 1 | 2019 | 899 | 0.490 |
Why?
|
| Coronary Artery Disease | 8 | 2022 | 6544 | 0.480 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2019 | 575 | 0.470 |
Why?
|
| Embolism, Paradoxical | 1 | 2014 | 56 | 0.460 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2019 | 855 | 0.430 |
Why?
|
| Hypertension | 4 | 2019 | 8626 | 0.410 |
Why?
|
| Cicatrix | 4 | 2020 | 798 | 0.410 |
Why?
|
| Stroke Volume | 4 | 2024 | 5596 | 0.410 |
Why?
|
| Myocardial Infarction | 5 | 2022 | 11499 | 0.400 |
Why?
|
| Magnetic Resonance Imaging | 16 | 2022 | 36532 | 0.390 |
Why?
|
| Foramen Ovale, Patent | 1 | 2014 | 211 | 0.390 |
Why?
|
| Predictive Value of Tests | 14 | 2022 | 15398 | 0.370 |
Why?
|
| Fibrosis | 5 | 2020 | 2070 | 0.340 |
Why?
|
| Heart | 7 | 2022 | 4414 | 0.330 |
Why?
|
| Aortic Valve | 1 | 2019 | 1968 | 0.320 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2019 | 2136 | 0.300 |
Why?
|
| Coronary Disease | 1 | 2022 | 5912 | 0.290 |
Why?
|
| Heart Ventricles | 1 | 2019 | 3832 | 0.280 |
Why?
|
| Proteomics | 3 | 2016 | 3910 | 0.270 |
Why?
|
| Contrast Media | 5 | 2020 | 5329 | 0.270 |
Why?
|
| Heart Rate | 3 | 2019 | 4204 | 0.260 |
Why?
|
| Venous Thrombosis | 1 | 2014 | 1327 | 0.240 |
Why?
|
| Organometallic Compounds | 2 | 2019 | 644 | 0.240 |
Why?
|
| Peptides | 2 | 2016 | 4331 | 0.230 |
Why?
|
| Exercise Test | 2 | 2024 | 2180 | 0.220 |
Why?
|
| Cardiomyopathy, Dilated | 2 | 2020 | 845 | 0.220 |
Why?
|
| Coronary Angiography | 4 | 2019 | 4493 | 0.190 |
Why?
|
| Middle Aged | 24 | 2024 | 223009 | 0.180 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2022 | 326 | 0.170 |
Why?
|
| Endomyocardial Fibrosis | 1 | 2020 | 41 | 0.170 |
Why?
|
| Stroke | 1 | 2022 | 9747 | 0.170 |
Why?
|
| Milk | 1 | 2022 | 436 | 0.160 |
Why?
|
| Aged | 19 | 2024 | 171117 | 0.160 |
Why?
|
| Meglumine | 1 | 2019 | 143 | 0.150 |
Why?
|
| Male | 27 | 2024 | 363698 | 0.150 |
Why?
|
| Cardiovascular Diseases | 2 | 2022 | 15652 | 0.150 |
Why?
|
| Female | 28 | 2024 | 396112 | 0.140 |
Why?
|
| Blood Pressure | 2 | 2012 | 8532 | 0.140 |
Why?
|
| Fabry Disease | 1 | 2017 | 90 | 0.130 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2020 | 4034 | 0.130 |
Why?
|
| Accreditation | 1 | 2019 | 477 | 0.130 |
Why?
|
| Angina Pectoris | 1 | 2019 | 956 | 0.120 |
Why?
|
| Sarcoidosis | 1 | 2020 | 532 | 0.120 |
Why?
|
| Blood Flow Velocity | 1 | 2018 | 1381 | 0.120 |
Why?
|
| Adult | 16 | 2020 | 223044 | 0.110 |
Why?
|
| Urinalysis | 1 | 2016 | 368 | 0.110 |
Why?
|
| Heart Conduction System | 1 | 2019 | 1006 | 0.110 |
Why?
|
| Humans | 33 | 2024 | 765968 | 0.110 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2014 | 235 | 0.110 |
Why?
|
| Pneumopericardium | 1 | 2012 | 7 | 0.110 |
Why?
|
| Observer Variation | 1 | 2019 | 2615 | 0.100 |
Why?
|
| Respiration | 1 | 2018 | 1653 | 0.100 |
Why?
|
| Case-Control Studies | 3 | 2019 | 22223 | 0.100 |
Why?
|
| Diagnostic Errors | 1 | 2019 | 1275 | 0.100 |
Why?
|
| Action Potentials | 1 | 2019 | 1838 | 0.090 |
Why?
|
| Cardiomyopathies | 2 | 2020 | 2067 | 0.090 |
Why?
|
| Electrophoresis, Capillary | 1 | 2010 | 63 | 0.090 |
Why?
|
| Defibrillators, Implantable | 1 | 2020 | 1490 | 0.090 |
Why?
|
| Retrospective Studies | 7 | 2020 | 81514 | 0.080 |
Why?
|
| Severity of Illness Index | 2 | 2019 | 15880 | 0.080 |
Why?
|
| Vomiting | 1 | 2012 | 647 | 0.080 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2019 | 2247 | 0.080 |
Why?
|
| Quality Indicators, Health Care | 1 | 2019 | 1806 | 0.080 |
Why?
|
| Reproducibility of Results | 4 | 2019 | 20124 | 0.080 |
Why?
|
| Recovery of Function | 1 | 2019 | 2966 | 0.080 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2019 | 1566 | 0.080 |
Why?
|
| Calcium | 1 | 2022 | 5767 | 0.080 |
Why?
|
| Heart Failure | 2 | 2024 | 11840 | 0.070 |
Why?
|
| Prospective Studies | 6 | 2022 | 54802 | 0.070 |
Why?
|
| Exercise | 1 | 2024 | 5937 | 0.070 |
Why?
|
| Endothelium | 1 | 2010 | 767 | 0.070 |
Why?
|
| Sus scrofa | 2 | 2019 | 430 | 0.070 |
Why?
|
| Risk Factors | 5 | 2022 | 74840 | 0.070 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2010 | 707 | 0.070 |
Why?
|
| Echocardiography | 1 | 2019 | 5045 | 0.070 |
Why?
|
| Longitudinal Studies | 1 | 2022 | 14751 | 0.060 |
Why?
|
| Phantoms, Imaging | 3 | 2018 | 2475 | 0.060 |
Why?
|
| Glomerular Filtration Rate | 1 | 2013 | 2233 | 0.060 |
Why?
|
| Chronic Disease | 1 | 2019 | 9347 | 0.060 |
Why?
|
| Quality Improvement | 1 | 2019 | 3853 | 0.060 |
Why?
|
| Incidence | 1 | 2022 | 21480 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 12976 | 0.050 |
Why?
|
| Clinical Competence | 1 | 2019 | 4863 | 0.050 |
Why?
|
| Pre-Eclampsia | 1 | 2012 | 1261 | 0.050 |
Why?
|
| Young Adult | 6 | 2019 | 59889 | 0.050 |
Why?
|
| Diabetes Mellitus | 1 | 2020 | 5891 | 0.050 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 26318 | 0.040 |
Why?
|
| Proteome | 1 | 2010 | 1899 | 0.040 |
Why?
|
| Cholesterol, LDL | 1 | 2010 | 2393 | 0.040 |
Why?
|
| Numerical Analysis, Computer-Assisted | 1 | 2020 | 120 | 0.040 |
Why?
|
| Artifacts | 2 | 2018 | 1893 | 0.040 |
Why?
|
| Animals | 6 | 2022 | 168764 | 0.040 |
Why?
|
| Supine Position | 1 | 2019 | 209 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2020 | 8923 | 0.040 |
Why?
|
| Swine | 2 | 2018 | 5988 | 0.040 |
Why?
|
| Phenotype | 2 | 2017 | 16721 | 0.040 |
Why?
|
| Normal Distribution | 1 | 2018 | 267 | 0.040 |
Why?
|
| Tissue Survival | 1 | 2018 | 121 | 0.040 |
Why?
|
| Aorta, Thoracic | 1 | 2024 | 1103 | 0.040 |
Why?
|
| Kidney | 1 | 2013 | 7066 | 0.040 |
Why?
|
| Image Enhancement | 2 | 2018 | 2858 | 0.040 |
Why?
|
| Obesity | 1 | 2020 | 13076 | 0.040 |
Why?
|
| alpha-Galactosidase | 1 | 2017 | 59 | 0.040 |
Why?
|
| Boston | 2 | 2020 | 9338 | 0.030 |
Why?
|
| Patient Positioning | 1 | 2019 | 328 | 0.030 |
Why?
|
| Models, Theoretical | 2 | 2018 | 3564 | 0.030 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2019 | 511 | 0.030 |
Why?
|
| Magnetics | 1 | 2018 | 585 | 0.030 |
Why?
|
| Automation | 1 | 2018 | 585 | 0.030 |
Why?
|
| Prognosis | 1 | 2016 | 29922 | 0.030 |
Why?
|
| Motion | 1 | 2018 | 781 | 0.030 |
Why?
|
| Computer Simulation | 2 | 2018 | 6255 | 0.030 |
Why?
|
| Myocardial Contraction | 1 | 2020 | 1515 | 0.030 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2010 | 3251 | 0.030 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2019 | 1145 | 0.030 |
Why?
|
| United States | 1 | 2022 | 72903 | 0.030 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2019 | 669 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2019 | 65188 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2012 | 41649 | 0.020 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2018 | 1456 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2020 | 14652 | 0.020 |
Why?
|
| Heterozygote | 1 | 2017 | 2794 | 0.020 |
Why?
|
| Pedigree | 1 | 2017 | 4526 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 18293 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2019 | 2780 | 0.020 |
Why?
|
| Superoxides | 1 | 2010 | 383 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2019 | 5302 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2017 | 2589 | 0.020 |
Why?
|
| Algorithms | 2 | 2018 | 14071 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 2017 | 2098 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2020 | 3985 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2019 | 8733 | 0.020 |
Why?
|
| Comorbidity | 1 | 2020 | 10563 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2013 | 1884 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2019 | 59489 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2010 | 2194 | 0.010 |
Why?
|
| Prevalence | 1 | 2020 | 15842 | 0.010 |
Why?
|
| Genotype | 1 | 2017 | 13024 | 0.010 |
Why?
|
| ROC Curve | 1 | 2010 | 3620 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2013 | 3141 | 0.010 |
Why?
|
| Child | 2 | 2019 | 80564 | 0.010 |
Why?
|
| Adolescent | 2 | 2019 | 88835 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2012 | 6404 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2020 | 24282 | 0.010 |
Why?
|
| Time Factors | 1 | 2019 | 40065 | 0.010 |
Why?
|
| Brain | 1 | 2017 | 27171 | 0.010 |
Why?
|
| Pregnancy | 1 | 2012 | 30260 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 20659 | 0.010 |
Why?
|
Concepts
(156)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(12)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_